Investing Profile

Heather Roxborough

InvestorVC
Partner at Optum Ventures
Photo of Heather Roxborough, Partner at Optum Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Johnson & Johnson Network
17 CONNECTIONS
cb
$100K - $5.0M
$1.5M
9
$250M
CompanyStageDateRound SizeTotal Raised
Neu Health
SeedJan 2025$2M
$2M
Amber Therapeutics
Series AJun 2024$100M
$100M
Co-investors: Ali Behbahani (New Enterprise Associates (NEA)), Tiffany Le (New Enterprise Associates (NEA)), Kevin Chu (F-Prime Capital Partners), Caroline Gaynor (Lightstone Ventures)
Navenio
Series ASep 2023$6M
Series UnknownDec 2021$13M
$46M
Co-investors: Ed Phillips (Future Planet Capital)
Caristo Diagnostics
Series AApr 2023$16M
$16M
Co-investors: Ian Downing (Business Growth Fund)
Kaia Health
Series CApr 2021$75M
Series BJun 2020$26M
Series ASep 2019$8M
$150M
Co-investors: James Wise (Balderton Capital), Christian Jepsen (Heartcore Capital), Antoine Zins (Eurazeo), Roman Scharf (3VC), Peter Lasinger (3VC), Florian Huber
icometrix
Series AMay 2019$18M
$18M
COMEDY CLUBS
Senior Director, New Ventures & Transactions Johnson & Johnson2017 - 2018
Principal Tate & Lyle Ventures2013 - 2016
Investment Manager Mercia Asset Management PLC2010 - 2013